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Abstract: Adult T-cell leukemia (ATL) is one of the primary diseases caused by Human T-
cell Leukemia Virus type 1 (HTLV-1) infection. The virally-encoded Tax protein is 
believed to initiate early events in the development of this disease, as it is able to promote 
immortalization of T-cells and transformation of other cell types. These processes may be 
aided by the ability of the viral protein to directly deregulate expression of specific cellular 
genes through interactions with numerous transcriptional regulators. To identify gene 
promoters where Tax is localized, we isolated Tax-DNA complexes from an HTLV-1-
infected T-cell line through a chromatin immunoprecipitation (ChIP) assay and used the 
DNA to probe a CpG island microarray. A site within the RNASET2 gene was found to be 
occupied by Tax. Real-time PCR analysis confirmed this result, and transient expression of 
Tax in uninfected cells led to the recruitment of the viral protein to the promoter. This 
event correlated with a decrease in the level of RNase T2 mRNA and protein, suggesting 
that Tax represses expression of this gene. Loss of RNase T2 expression occurs in certain 
hematological malignancies and other forms of cancer, and RNase T2 was recently reported 
to function as a tumor suppressor. Consequently, a reduction in the level of RNase T2 by 
Tax may play a role in ATL development.  
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1. Introduction 
Human T-cell Leukemia Virus type 1 (HTLV-1) is a complex retrovirus that causes a fatal form of 
leukemia known as adult T-cell leukemia (ATL) [1]. This disease occurs through the clonal expansion 
and subsequent transformation of one or possibly a few HTLV-1-infected CD4+ T-cells, which are the 
primary target of the virus. The virally-encoded Tax protein is believed to be critically involved in the 
development of ATL. Tax has been shown to be oncogenic through its ability to transform murine 
fibroblasts in a Ras-dependent manner, immortalize primary T-cells, and cause tumors in transgenic 
mice [2]. Moreover, transgenic mice that express Tax specifically through the LCK promoter in the 
thymus exhibit some pathological conditions similar to those of ATL patients [3]. Overall, these effects 
are believed to arise from the ability of Tax to stimulate cell proliferation and inhibit apoptosis, while 
concomitantly promoting increased DNA damage and genome instability [4]. 
The deregulation of cellular processes by Tax is frequently caused by changes in gene expression. 
At the HTLV-1 promoter, Tax functions as a transcriptional activator through the formation of a highly 
stable complex with the transcription factor CREB and the coactivator p300/CBP [5]. In the context of 
cellular genes, Tax activates transcription indirectly through stimulation of NFκB and Akt signaling 
and directly through interactions with CREB and SRF [2]. Interestingly, the association of Tax with 
CREB on some promoters also inhibits transcription, potentially by blocking interactions between 
CREB and positive regulators [6,7]. Tax has also been found to repress transcription by binding 
directly to p300 and CBP and sequestering the coactivators away from activator complexes at cellular 
promoters [8]. This model defines how Tax classically inhibits transcriptional activation by basic 
helix-loop-helix factors [9,10], although separate mechanisms are also involved [11]. Overall, the 
direct effects of Tax on cellular gene expression are mediated by interactions between the viral protein 
and a large array of transcriptional regulators [12], as Tax alone does not bind DNA. 
In lieu of the oncogenic properties of Tax, less than five percent of the HTLV-1-infected population 
develops ATL, with the disease normally occurring decades after the initial infection [1]. Therefore, 
environmental, hereditary and other factors may dictate whether Tax helps trigger the proliferation, 
survival and, ultimately, transformation of an infected T-cell. It is also possible that Tax itself may 
contribute to the low incidence of ATL, as Tax is known to induce apoptosis, an outcome that 
frequently predominates over its proliferative and pro-survival effects [13]. Similarly, Tax induces 
senescence in certain cell-types through the upregulation of the cyclin-dependent kinase inhibitors p21 
and p27 [14,15]. Interestingly, results from a recent report demonstrate that a small fraction of the 
senescent cells can reenter the cell cycle, although it is unclear whether Tax is involved in this 
process [16]. 
Ribonuclease T2 (RNase T2) is known to play a role in senescence in plants and possibly 
mammalian cells [17,18]. This protein may be an important tumor suppressor, as it is located within a 
region of the long arm of chromosome six that undergoes deletion or rearrangement in many cancers, 
including some cases of ATL [19,20]. Although this classification has been challenged [21,22], results 
from many studies link RNase T2 expression to inhibited growth of immortalized and tumor cells 
[17,23–27]. Recently, a definitive tumor suppressor function for RNase T2 was characterized in vivo 
using a mouse model, indicating that inhibition of tumor growth by RNase T2 mainly occurs in the 
context of the tumor microenvironment [26]. 
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In the current study, we found that Tax is recruited to the RNASET2 gene. This interaction was 
identified using chromatin immunoprecipitated (ChIPed) DNA from MT-2 cells to probe a microarray 
and was confirmed using quantitative real-time PCR (qPCR) analysis of ChIPed DNA. In addition, Tax 
from an HTLV-1-infected cell nuclear extract bound to a region of the RNASET2 gene in an 
immobilized template-binding assay. The association of Tax with this region repressed RNase T2 
expression. Two Tax-interacting partners, Brm, which is one of the core subunits of the SWI/SNF 
complex, and histone deacetylase 1 (HDAC1), bound to the same region of the RNASET2 gene as Tax. 
Given that these proteins appeared to associate with the gene independent of Tax, it is possible that 
they facilitate in the recruitment of the viral protein to the gene. 
2. Results and Discussion 
2.1. Tax Is Enriched at the RNASET2 Gene 
Tax predominantly localizes to the nucleus where it is able to interact with several cellular 
transcription factors and other transcriptional regulators. These properties allow Tax to associate with 
specific DNA-bound protein complexes and influence gene expression. To identify genomic sites 
directly targeted by Tax, DNA fragments associated with protein complexes containing Tax were 
isolated by chromatin immunoprecipitation (ChIP) from the HTLV-1-infected T-cell line, MT-2, using 
a Tax-specific antibody. Following amplification and fluorescent labeling, ChIP DNA was used to 
probe a CpG island microarray, as CpG islands are frequently found within transcriptionally active 
regions of the genome. Through this approach we identified a region of the RNASET2 gene (+1071 to 
+1366 with respect to the RNA start site) as a possible Tax-binding site. To verify this result, we 
quantified relative levels of Tax enrichment at various genomic sites through qPCR analysis of ChIP 
samples obtained from different HTLV-1-infected cell lines. In each cell line, the level of Tax 
enrichment at the RNASET2 gene was compared with levels of enrichment at the HTLV-1 promoter 
(a known Tax-binding site) and within the proviral gag gene (negative for Tax). Two additional 
negative sites were also evaluated: the AKT1S1 promoter, which did not exhibit Tax enrichment in the 
microarray analysis, and the DKK1 promoter, which is indirectly regulated by Tax [28]. Surprisingly, 
although we originally identified the RNASET2 site from the microarray analysis using MT-2 cells, Tax 
enrichment at this position was only slightly greater than at the three negative sites (Figure 1a). In 
contrast, Tax-binding to the RNASET2 gene was more pronounced in C8166/45 and ATL-2 cells 
(Figures 1b,c). In all three cell lines, the HTLV-1 promoter exhibited the strongest signal for Tax 
consistent with the presence of multiple binding sites for Tax-containing complexes within this region 
of the DNA. It is important to note that small amounts of nonspecific protein-DNA complexes may 
co-purify with specific complexes in ChIP assays. This phenomenon leads to a background signal at 
negative sites that is detected by real-time PCR. Furthermore, in the case of the gag site, a fraction of 
the fragmented chromatin that is coimmunoprecipitated with Tax is longer than the 683 base pairs 
separating this position and the HTLV-1 promoter. Therefore, some chromatin may contain both sites 
even though Tax is bound to the HTLV-1 promoter. 
We corroborated ChIP results in vitro using an immobilized template-binding assay in which we 
isolated protein complexes from an HTLV-1-infected cell nuclear extract using various DNA templates 
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linked to Dynabeads. High levels of Tax were retained on the HTLV-1 promoter and on the region of 
RNASET2 gene encompassing +1069 to +1545 with respect to the predicted transcription start site. In 
contrast, substantially less Tax was retained on the DKK1 promoter, which was negative for Tax in 
ChIP assays (Figure 1d). The nuclear extract used was prepared from SLB-1 cells, which showed 
specific binding of Tax to the HTLV-1 promoter and the RNASET2 gene (Figure 1e). 
Figure 1. The association of Tax with the RNASET2 gene. (a) Enrichment signals for Tax 
at the HTLV-1 promoter, the RNASET2 gene (+1069 to +1153), the ALT1S1 promoter and 
the DKK1 promoter were determined by qPCR analysis of ChIP samples relative to the Tax 
signal at the gag site in MT-2 cells. The 2CT(Input)−CT(IP) values obtained at each site were 
normalized to the value obtained at gag, which was set to 1. The graph shows data 
averaged from independent ChIP assays. Error bars show standard deviations. No standard 
deviation is shown for gag, as values at this site were set to 1 to normalize data among 
ChIP assays. The asterisk denotes a p-value of 0.015 for a two-tailed Student t-test. 
(b) Enrichment signals for Tax in C8166/45 cells (n = 4; p = 0.004). (c) Enrichment signals 
for Tax in ATL-2 cells (n = 4; p = 0.003). (d) The Western blot shows Tax from an SLB-1 
cell nuclear extract retained on immobilized DNA templates that separately contained the 
HTLV-1, DKK1 and RNASET2 regions from –306 to –1, −539 to –244, and +1069 to 
+1545, respectively. (e) PCR analysis of ChIP samples shows specific Tax binding at the 
HTLV-1 promoter and RNASET2 gene. Coimmunoprecipitation using preimmune rabbit 
serum (IgG) and amplification of the gag site were performed as negative controls. Each 
panel shows amplification of 1% of the total input chromatin (input). 
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The region of the RNASET2 gene where Tax binds was further defined in MT-2 and C8166/45 cells 
using ChIP assays followed by qPCR amplification of three separate portions of the gene. The regions 
tested were centered at +605, +1111 and +1496 with respect to the RNA start site. The highest 
Tax-enrichment was observed at the +1111 site (Figure 2a). Because this approach provided a low 
resolution picture of where Tax is recruited on the promoter, we also used the immobilized 
template-binding assay to compare levels of Tax retained by various fragments of the RNASET2 gene. 
Stronger Tax signals were detected using fragments encompassing +489 to +1153 and +489 to +1092 
of the gene than those spanning +1130 to +1545 and +1201 to +1545 (Figure 2b). In Figure 1B, Tax 
was retained on a RNASET2 promoter fragment encompassing +1069 to +1545. Therefore, the overall 
results from these assays suggest that Tax is recruited to the region from +1069 to +1092. This site is 
within the translated portion of the gene (the translational start site is at +408). An analysis of this 
DNA sequence using MatInspector [29] (Genomatix.de) revealed cis-elements for PRDM1/Blimp-1, 
NK6 and NKX homeodomain factors, and MYT1, but not for any known Tax-binding partners. 
Figure 2. Levels of Tax enrichment at various regions of the RNASET2 gene. (a) Levels of 
Tax enrichment at RNASET2 gene sites centered at +605, +1111 and +1496 were 
determined by qPCR analysis of ChIP samples from MT-2 and C8166/45 cells. For each 
ChIP assay, the 2CT(Input)−CT(IP) values for the three sites were added. The sums were then 
normalized to 1, and the 2CT(Input)−CT(IP) values from each amplicon of a ChIP were 
multiplied by the normalization factor for that ChIP. The graph shows data from six and 
four ChIP assays for MT-2 and C8166/45 cells, respectively. Error bars show standard 
deviations. The asterisk denotes significantly higher enrichment of Tax at the +1111 site 
according to a Scheffé post hoc comparison preceded by ANOVA: F(2,15) = 9.69, p < 0.05 
for MT-2; F(2,9) = 11.33, p < 0.05 for C8166/45. (b) Depicted are the RNASET2 gene from 
+489 to +1545, the promoter deletion templates that were tested for Tax-binding, and the 
relative position of the +1111 amplicon that exhibited peak Tax-enrichment in ChIP assays. 
The Western blot shows Tax from an SLB-1 cell nuclear extract retained on immobilized 
DNA templates encompassing the different regions of the RNASET2 gene. 
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2.2. Tax Represses Expression of RNase T2 
To determine whether Tax alters the level of RNase T2 expression, we transfected HeLa cells with 
an expression vector for Tax or with the empty vector. In ChIP assays we found that Tax expression 
leads to enrichment of the viral protein over background detection at the RNASET2 gene (Figure 3a), 
confirming that Tax is recruited to this site in these cells. This effect coincided with a decrease in the 
level of RNase T2 mRNA and protein (Figures 3b and 3c, respectively), indicating that Tax represses 
expression of this gene. Similar results were obtained using Hut-78 cells (Figure 3d), suggesting a 
similar effect in T-cells. 
Figure 3. The effect of Tax on RNase T2 expression. (a) Recruitment of Tax to the 
RNASET2 gene was assessed by comparing levels of Tax enrichment at the promoter in 
HeLa cells transfected with the pSG-5 empty vector (−) or the pSG-Tax expression 
vector (+). The graph shows the average 2CT(Input)−CT(IP) values obtained for rabbit 
preimmune serum (IgG; used as a negative control) and for the Tax ChIP from five 
independent transfection/ChIP assays. Error bars show standard deviations. The asterisk 
denotes a p-value of 0.04 for a two-tailed Student t-test. (b) Relative levels of RNase T2 
mRNA from HeLa cells transfected with pSG-5 (−) and pSG-Tax (+) were assessed by 
qRT-PCR. The graph shows the average 2−∆∆CT values from six independent transfection 
assays. The error bar shows the standard deviation. No standard deviation is shown for 
pSG-5, as it was used as the control treatment and set to 1 to show a relative difference in 
the mRNA level of the experimental treatment (pSG-Tax). The asterisk denotes a p-value 
of 0.009 for a two-tailed Student t-test. (c) The protein levels of RNase T2, Tax and actin 
from HeLa cells transfected with pSG-5 (−) or pSG-Tax (+) were assessed by Western blot. 
(d) Relative levels of RNase T2 mRNA from Hut-78 cells transfected with pSG-5 (−) or 
pSG-Tax (+) were assessed by qRT-PCR. The graph shows the average 2−∆∆CT values from 
two independent transfection assays. 
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Figure 3. Cont. 
 
 
We also compared relative levels of RNase T2 mRNA among a panel of HTLV-1-infected T-cell 
lines with that of CD4+ T-cells. We found that RNase T2 expression was reduced in five of the six cell 
lines tested (Figure 4). Surprisingly, MT-2 cells did not show a decrease in the transcript level 
compared to CD4+ T-cells. It is possible that Tax is ineffective in repressing RNase T2 expression 
when it is weakly associated with the gene, as suggested by ChIP data from MT-2 cells shown in 
Figure 1a. Interestingly, TL-OmI cells exhibited a low level of RNase T2 mRNA even though they do 
not express Tax. This observation may coincide with findings that the NF-κB pathway remains 
constitutively active in ATL cells lacking Tax [30,31], suggesting that some effects of Tax are retained 
in the transformed cells after expression of the viral protein is lost. Importantly, TL-OmI cells (and 
ATL-2 cells) are derived directly from an ATL patient. 
Figure 4. Levels of RNase T2 mRNA among HTLV-1-infected T-cell lines. Relative levels 
of RNase T2 mRNA from the cell lines and normal CD4+ T-cells were assessed by  
qRT-PCR. The graph shows the average 2−∆∆CT values from two independent RNA 
extractions. Levels were normalized to that from one of the CD4+ T-cell specimens (set 
to 1). Error bars show standard deviations. 
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2.3. Brm1, HDAC1 and Tax Exhibit Overlapping Patterns of Enrichment on the RNASET2 Gene 
To gain insight into how Tax associates with, and regulates transcription from the RNASET2 gene, 
we used ChIP assays to identify proteins that colocalize to the same region of the gene as Tax. Because 
the DNA region targeted by Tax did not contain cis-elements for transcription factors known to 
associate with Tax, we focused mainly on interacting partners that repress transcription and do not bind 
directly to DNA. Protein-binding patterns at the RNASET2 gene +605, +1111 and +1496 sites are 
shown in Figure 5a. In order to compare these patterns, we equalized the signals for the proteins 
represented in the graph (see legend), as the signal varied among the different antibodies used for the 
ChIP assays. A pattern matching that for Tax was observed with Brm, which is one of two 
interchangeable catalytic subunits of the SWI/SNF chromatin remodeling complex [32]. Interestingly, 
the homologous subunit, Brg-1, did not exhibit the same pattern of binding although it was this subunit 
that was isolated in a protein complex with Tax [33]. The histone deacetylase, HDAC1, also showed 
binding similar to Tax, while HDAC3 did not. Although these proteins have overlapping functions and 
interact with Tax [34,35], they are frequently found in separate repressor complexes [36]. CREB did 
not exhibit significant enrichment at the +1111 site compared to the flanking sites. This result was 
expected, as the +1111 site does not carry a consensus CRE, and CREB plays a positive role with Tax 
in activation of HTLV-1 transcription [5]. Signals for Brm and HDAC1 were significantly greater 
at the RNASET2 +1111 site than at the HTLV-1 promoter (Figure 5b). In an immobilized 
template-binding assay, Brm and HDAC1 bound more efficiently to the +489/+1153 and +489/+1092 
fragments of the RNASET2 gene than the +1130/+1545 and +1201/+1540 templates, which parallels 
results obtained for Tax (Figure 5c). To determine whether Tax mediated the recruitment of these 
proteins to the RNASET2 gene, we performed immobilized template-binding assays using nuclear 
extract derived from uninfected T-cells (CEM cells) and supplemented some reactions with 
recombinant, purified Tax (Figure 5d). We found that Brm and HDAC1 were efficiently retained on 
the template containing the target site for Tax in the absence of the viral protein. Addition of Tax did 
not augment binding of these proteins to the template, suggesting that Tax does not play a role in the 
recruitment of Brm and HDAC1 to RNASET2 gene. 
3. Experimental Section 
3.1. Cell Culture, Transfection and Western Blot Analysis 
T-cell lines were cultured in Iscove’s modified Dulbecco medium (IMDM) supplemented with 10% 
fetal bovine serum, 2 mM L-glutamine, 100 U/mL penicillin, and 50 µg/mL streptomycin. HeLa cells 
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented as above. HeLa cells 
were transfected by electroporation as described [37], using cotransfection of pMACS 4.1 and the 
MACSelect system (Miltenyi Biotec) to purify transfected cells [38]. The expression vectors used in 
this study were pSG-5 and pSG-Tax [39]. HUT-78 cells were transfected by electroporation using a 
Gene Pulser Xcell (Bio-Rad) with 1 × 107 cells in 675 uL RPMI/10 mM dextrose/0.1 mM 
dithiothreitol and 20 µg plasmid DNA (3:1 stiochiometric ratio of the expression vector of interest to 
pMACS Kk.II) per 0.4 cm cuvette. Each cuvette was subjected to a single exponential decay pulse of 
300 V/250 µF. Four cuvettes were pulsed per vector. Electroporated cells were cultured 48 h. Live cells 
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were collected by centrifugation on Ficoll-Paque PLUS (GE Healthcare) as described by the 
manufacturer, and transfected cells were purified using the MACSelect system. Western blots were 
performed as described [40]. 
3.2. Chromatin Immunoprecipitation (ChIP) Assays and Microarray Analysis 
ChIP assays for real-time PCR analysis were performed as described [41]. For some assays, cell 
lysates were sonicated using a Misonix Sonicator 4000 by pulsing samples in cold water in a 5.5 inch 
cup horn 15 times at an amplitude of 60 for 20 s with 30 s rests between pulses. For the microarray 
analysis, the ChIP assay was altered by replacing salmon sperm DNA with 0.5 mg/mL tRNA 
(Invitrogen) for the immunoprecipitation step. The total DNA from a single immunoprecipitation (IP) 
and 10 ng of input DNA were processed and amplified by ligation-mediated PCR as described [42]. 
Aminoallyl-dUTP was randomly incorporated into the DNA and coupled with the Cy3 (input) or Cy5 
(IP) fluorescent dye as described [42]. Samples were combined to probe 12.2 K CpG island microarray 
(University Health Network Microarray Center, Princess Margaret Hospital, Ontario Cancer Center, 
Canada) [43], using hybridization conditions described [44]. Data was analyzed as described [42]. 
Antibodies against Brg-1 (sc-10768), Brm (sc-6450), HDAC1 (sc-7872) and HDAC3 (sc-11417) were 
from Santa Cruz Biotechnology. The antibody against CREB was from Millipore (06-863). The 
antibody against Tax was from the NIH AIDS Research and Reference Reagent Program (hybridoma 
168B17–46-92). 
3.3. Real-Time PCR 
Real-time PCR and subsequent analyses were performed as described [28]. The following primers 
were used for ChIP samples:  
vCRE-F, 5′-ATCATAAGCTCAGACCTCCGGGAA; vCRE-R, 
5′-CCTGAGGACGGCTTGACAAACAT; Gag-F, 5-CGCTCATCACTGGCTTAACTTCCT; Gag-R, 
5′-TGGTGGAAATCGTAACTGGAGGGA; RNaseT2+1496F, 
5′-CGGTGCTGCAAAGAACTCCAACTT; RNaseT2+1496R, 
5′-TCCTATTAACCCGATCATTACCCA; RNaseT2+1111F, 
5′-AGCCAAGGGAAGGGATTCAGAACA; RNaseT2+1111R, 
5′-TAATTTCAGCTTTCACTGCGGCGG; RNaseT2+605F, 
5′-CGCTGCTCAACTTCCCAACTTCTT; RNaseT2+605R, 
5′-CCCTAGAGCTTTCCACTGGGTGAA; DKK1-331F and DKK1-331R [28].  
RNA extraction, cDNA sythesis, qRT-PCR and data analysis were performed as described [28]. The 
following primers were used for cDNA samples: RT-RNaseT2F, 5′-ACTGGCCTGACGTAATTCACTCGT; 
RT-RNaseT2R, 5′-TGTAGAGTTCCAGGCTTCTGCCAA; UBE2D2-F and UBE2D2-R [28]. 
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Figure 5. The association of Brm and HDAC1 with the RNASET2 gene and the HTLV-1 
promoter. (a) Levels of Brm, HDAC1, Brg-1, HDAC3 and CREB enrichment at sites 
centered at +605, +1111 and +1496 were determined by qPCR analysis of ChIP samples 
from MT-2, C8166/45 and SLB-1 cells. For each ChIP assay, the 2CT(Input)−CT(IP) values for 
the three amplicons were added. The sums were then normalized to 1, and the 
2CT(Input)−CT(IP) values from each amplicon of a ChIP were multiplied by the normalization 
factor for that ChIP. Error bars show standard deviations. Asterisks denote significantly 
higher enrichment of Tax at the +1111 site according to a Scheffé post hoc comparison 
preceded by ANOVA: F(2,6) = 26.38, p < 0.01 for Brm (tested in C8166/45 cells); F(2,9) = 
11.87, p < 0.05 for HDAC1 (tested in C8166/45 and SLB-1 cells). Data for CREB 
represent the average normalized enrichment from three independent ChIP assays using 
C8166/45 and MT-2 cells. Data for Brg1 and HDAC3 represent the average normalized 
enrichment from two ChIP assays using C8166/45 and MT-2 cells. (b) Levels of Brm and 
HDAC1 associated with the HTLV-1 and RNASET2 genes in C8166/45 cells were 
determined by qPCR analysis of ChIP samples. The 2CT(Input)−CT(IP) value obtained with primer 
sets for the RNASET2 +1111 site was normalized to the value obtained with the HTLV-1 
primer set, which was set to 1. The graph shows data averaged from two independent ChIP 
assays for each protein. Error bars show standard deviations. (c) The Western blots show Brm 
and HDAC1 from an SLB-1 cell nuclear extract retained on immobilized DNA templates 
encompassing the different regions of the RNASET2 gene. (d) The Western blots show Brm 
and HDAC1 from a CEM nuclear extract retained on the indicated RNASET2 gene templates 
in the absence and presence of recombinant, purified Tax. 
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3.4. Immobilized Template-Binding Assays 
Assays were performed essentially as described [45]. For each binding reaction, 2 pmol of a 
biotinylated DNA fragment was bound to 10 µL of M-280 streptavidin Dynabeads (Invitrogen) as 
described by the manufacturer and blocked in 500 µL ITB (0.1 M KCl, 20 mM HEPES [pH 7.9],  
1 mM MgCl2, 20 µM ZnSO4, 10% glycerol, 0.01% Triton X100, 0.5 mM EDTA, 0.5 mM PMSF,  
1 mM benzamidine, 5 mM DTT) with 5% BSA for 1 h at 4 °C. The blocked DNA-coupled beads were 
cleared, combined with 250–500 µg nuclear extract in a total volume of 500 µL of ITB/5% BSA, and 
mixed for 2 h at 4 °C. Nuclear extract was prepared from SLB-1 and CEM cells as described [46]. Tax 
was expressed and purified as described [47]. Tax (90 pmol) was preincubated with nuclear extract for 
1 h at 4 °C prior to adjusting reactions to 500 µL of ITB/5% BSA. Bead complexes were washed 
extensively with ITB. Bound proteins were resolved by SDS-PAGE and detected by Western blot using 
the same antibodies as those used for ChIP assays. 
4. Conclusions 
The oncogenic effects of Tax originate, in part, from its ability to deregulate expression of  
numerous genes. In some cases, Tax mediates changes in transcription directly from the cellular 
promoter [6,48–50]. In this study, we have identified such a situation. A screen for Tax-binding sites 
through a microarray analysis of ChIP samples identified the RNASET2 gene as a site targeted by the 
viral protein, and subsequent data supported this finding. Although Tax is often classified as a 
transcriptional activator, we found that expression of RNase T2 was repressed by the viral protein. This 
effect is not unique, as Tax has been reported to downregulate transcription of other cellular genes, 
including those encoding c-Myb, cyclin A, cyclin D3, α-polymerase, β-polymerase, Lck, p53, 
p18ink4C, SHP-1 and Znf268 [6,7,11,49,51–54]. 
Mechanisms of Tax-mediated repression that have emerged involve Tax interactions with CREB, 
p300/CBP, TAX1BP1, and HDAC1 [6–8,34,55]. Only repression through CREB and HDAC1 has 
been shown to occur through association of Tax with the target promoter in vivo [6,49]. On the 
RNASET2 gene, it is unlikely that CREB plays a role in repression, as CRE-like elements are absent 
from the Tax-binding region of the promoter, and CREB did not exhibit peak enrichment at this site. In 
contrast, HDAC1 and Brm did show a similar pattern of enrichment on the gene as Tax. However, their 
association with the gene does not appear to require Tax. Because Tax interacts with HDAC1 and 
multiple Brg-1 associated factors that form a complex with Brm [33,34], it is possible that these 
proteins assist in the recruitment of Tax to the RNASET2 gene. Although the mechanism of repression 
remains unclear, it is interesting that repression of Znf268 expression also involves recruitment of Tax 
within the transcribed portion of the gene [6]. It is therefore possible that, when bound to these 
downstream sites, Tax hinders transcriptional elongation. Further work is needed to test this hypothesis. 
The inhibitory effect of RNase T2 on tumor growth is largely seen in the context of the tumor 
microenvironment using a mouse model [26]. Therefore, how this protein functions as a tumor 
suppressor remains to be determined. In HTLV-1-infected cells, it is possible that reduced RNase T2 
expression by Tax helps prevent these cells from undergoing senescence or apoptosis due to other 
effects of the viral protein. Among its pleiotropic effects, Tax increases the prooxidant state within 
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cells, which can lead to senescence or apoptosis [56,57]. Recently, the yeast paralogue of RNase T2 
was shown to help mediate an apoptotic response to oxidative stress [58]. Therefore, in conjunction 
with higher levels of thioredoxin found in cells expressing Tax [59], concomitant lower levels of 
RNase T2 may be important for survival and proliferation. 
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